Therapeutic targeting at a pre-metastatic stage for brain metastases from lung cancer

Recent advances in CNS tumour management

Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer

Updates in head and neck cancers

KEYNOTE022: Triplet therapy for BRAF melanoma

First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma

SPLENDOUR: Added denosumab in first line adv NSCLC treatment

Cisplatin superior to cetuximab for HPV oropharyngeal cancer

Cisplatin v cetuximab for HPV associated oropharyngeal cancer

ESMO 2018: Melanoma highlights

KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma

The TRIBE-2 study for colorectal cancer